Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 200.75
-3.90 (-1.91%)
At close: May 5, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 95.87 billion as of May 6, 2026. Its market cap has increased by 165.96% in one year.
Market Cap
95.87B
Enterprise Value
100.84B
Revenue
18.17B
Ranking
n/a
PE Ratio
57.47
Stock Price
200.75
Market Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 95.87B, an increase of 27,468.40%. That is a compound annual growth rate of 30.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 95.87B | 5.70% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 205.84B |
| Granules India | 176.39B |
| Rubicon Research | 159.07B |
| Jubilant Pharmova | 148.66B |
| Caplin Point Laboratories | 132.41B |
| CORONA Remedies | 107.69B |
| Procter & Gamble Health | 85.67B |
| Sanofi India | 78.37B |